Over the last years it has started a real revolution in the treatment of chronic hepatitis C. This occurred for theavailability of direct-acting antiviral agents that allowto reach sustained virologic response in approximately90% of cases. In the near future further progress willbe achieved with the use of pan-genotypic drugs withhigh efficacy but without side effects.

Chronic hepatitis C: This and the new era of treatment

BERTINO, Gaetano;RAPISARDA, VENERANDO;Di Carlo I;
2016-01-01

Abstract

Over the last years it has started a real revolution in the treatment of chronic hepatitis C. This occurred for theavailability of direct-acting antiviral agents that allowto reach sustained virologic response in approximately90% of cases. In the near future further progress willbe achieved with the use of pan-genotypic drugs withhigh efficacy but without side effects.
2016
Direct-acting antiviral agents; Nucleoside inhibitors; Boceprevir; Telaprevir; Sofosbuvir; Simeprevir; Daclatasvir; Ledipasvir; Faldaprevir; Ritonavir; Ombitasvir; Dasabuvir
File in questo prodotto:
File Dimensione Formato  
WJH-8-92.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 1.06 MB
Formato Adobe PDF
1.06 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/47112
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 68
  • ???jsp.display-item.citation.isi??? 57
social impact